These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6703753)

  • 1. Therapeutic efficacy of phenytoin in recessive dystrophic epidermolysis. A comparison of short- and long-term treatment.
    Cooper TW; Bauer EA
    Arch Dermatol; 1984 Apr; 120(4):490-5. PubMed ID: 6703753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase.
    Bauer EA; Cooper TW; Tucker DR; Esterly NB
    N Engl J Med; 1980 Oct; 303(14):776-81. PubMed ID: 6251365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)].
    Wirth H; Nesch A; Ostapowicz B; Anton-Lamprecht I
    Z Hautkr; 1983 Apr; 58(8):555-74. PubMed ID: 6858283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of systemic phenytoin in the treatment of junctional epidermolysis bullosa.
    Fine JD; Johnson L
    Arch Dermatol; 1988 Sep; 124(9):1402-6. PubMed ID: 3415285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic considerations in recessive dystrophic epidermolysis bullosa.
    Bauer EA; Cooper TW
    Arch Dermatol; 1981 Sep; 117(9):529-30. PubMed ID: 6271076
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. Epidermolysis Bullosa Study Group.
    Caldwell-Brown D; Stern RS; Lin AN; Carter DM
    N Engl J Med; 1992 Jul; 327(3):163-7. PubMed ID: 1608407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of elastase-type activity in blister fluids of recessive dystrophic epidermolysis bullosa.
    Francès C; Meimon G; Herson S; Robert L
    Clin Physiol Biochem; 1986; 4(6):350-4. PubMed ID: 3643827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of esophageal stenosis in recessive dystrophic epidermolysis bullosa.
    Feurle GE; Weidauer H; Baldauf G; Schulte-Braucks T; Anton-Lamprecht I
    Gastroenterology; 1984 Dec; 87(6):1376-80. PubMed ID: 6436135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin therapy for junctional epidermolysis bullosa.
    Rogers RB; Yancey KB; Allen BS; Guill MF
    Arch Dermatol; 1983 Nov; 119(11):925-6. PubMed ID: 6639114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dilatation treatment of esophageal stenoses in young patients with recessive epidermolysis bullosa dystrophica].
    Seitz HK; Egerer G; Sina R; Baldauf G; Hartschuh W; Anton-Lamprecht I; Kommerell B
    Z Gastroenterol; 1990 Mar; 28(3):157-9. PubMed ID: 2343606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A perspective on the role of collagenase in recessive dystrophic epidermolysis bullosa.
    Bauer EA; Tabas M
    Arch Dermatol; 1988 May; 124(5):734-6. PubMed ID: 2835015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the National Epidermolysis Bullosa Registry.
    Fine JD; Johnson LB; Weiner M; Stein A; Cash S; DeLeoz J; Devries DT; Suchindran C;
    Am J Kidney Dis; 2004 Oct; 44(4):651-60. PubMed ID: 15384016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
    van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF
    J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry.
    Fine JD; Johnson LB; Weiner M; Stein A; Cash S; Deleoz J; Devries DT; Suchindran C
    Am J Ophthalmol; 2004 Aug; 138(2):254-62. PubMed ID: 15289135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Junctional epidermolysis bullosa. Treatment with phenytoin.
    Guill MF; Wray BB; Rogers RB; Yancey KB; Allen BS
    Am J Dis Child; 1983 Oct; 137(10):992-4. PubMed ID: 6613946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phenytoin in recessive dystrophic epidermolysis bullosa].
    Armoni M; Schlesinger M; Metzker A
    Harefuah; 1984 Nov; 107(10):285-7. PubMed ID: 6530171
    [No Abstract]   [Full Text] [Related]  

  • 17. Dermolytic (dystrophic) epidermolysis bullosa inversa.
    Pearson RW; Paller AS
    Arch Dermatol; 1988 Apr; 124(4):544-7. PubMed ID: 3355197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitor therapy for recessive dystrophic epidermolysis bullosa. In vitro effect and clinical trial with camostat mesylate.
    Ikeda S; Manabe M; Muramatsu T; Takamori K; Ogawa H
    J Am Acad Dermatol; 1988 Jun; 18(6):1246-52. PubMed ID: 3385039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recessive dystrophic epidermolysis bullosa treated with phenytoin.
    Abahussein AA; al-Zayir AA; Mostafa WZ; Okoro AN
    Int J Dermatol; 1992 Oct; 31(10):730-2. PubMed ID: 1399206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lethal cardiomyopathy in epidermolysis bullosa associated with amitriptyline.
    Taibjee SM; Ramani P; Brown R; Moss C
    Arch Dis Child; 2005 Aug; 90(8):871-2. PubMed ID: 16040888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.